Combination lipid therapy in type 2 diabetes

N Engl J Med. 2010 Aug 12;363(7):692; author reply 694-5. doi: 10.1056/NEJMc1006407.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cholesterol, HDL / blood*
  • Coronary Artery Disease / blood
  • Coronary Artery Disease / drug therapy*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Drug Therapy, Combination
  • Female
  • Fenofibrate / therapeutic use*
  • Humans
  • Hypertriglyceridemia / complications
  • Hypertriglyceridemia / drug therapy
  • Hypolipidemic Agents / therapeutic use*
  • Male
  • Proportional Hazards Models
  • Risk
  • Simvastatin / therapeutic use
  • Triglycerides / blood*

Substances

  • Cholesterol, HDL
  • Hypolipidemic Agents
  • Triglycerides
  • Simvastatin
  • Fenofibrate